Should I buy, hold, or sell CCAP stock right now?

Crescent Capital BDC Inc. (CCAP) currently earns a Roarable Rating of D (Sell — SELL) with 51/100 RQD Confidence. Stretched risk/reward at 10x P/E (-11% return on capital) under elevated 10-year interest-rate pressure.

What is CCAP's 12-month price target and RQD AI Jury consensus?

CCAP's 12-month base price target is $9.11 (range $7.11 to $15.94), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Financials / CCAP

RM (61) BRBI (45) GEMI (24) TREE (50) ⌘ Pro Terminal →

Crescent Capital BDC Inc. (CCAP) — RQD Stock Rating Cockpit

$9.41 +1.56% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.42

Crescent Capital BDC Inc. (CCAP) carries a Roarable Rating of D (Sell) with 51/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $341.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CCAP Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Crescent Capital BDC Inc. (NASDAQ: CCAP) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $9.41 (+1.56% 1D, market cap $341.6M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CCAP ranks #626 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CCAP compare to RM and BRBI in the Financials sector?

▼

Within the Financials sector (Finance: Consumer Services), CCAP carries a Roarable D (51/100 RQD), trailing P/E of 9.9x, gross margin of —, and ROIC of -11.1%. By comparison, RM (Regional Management Corp.) holds a C- grade (61/100 RQD, P/E 7.5x, ROIC 11.9%, cap $334.9M) and BRBI (BRBI BR Partners S.A. ADSs) posts a D grade (45/100 RQD, P/E N/A, ROIC —, cap $353.5M). Among the 5-stock peer group, RM leads on earnings multiple (7.5x) while RM leads on capital efficiency (11.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CCAP?

▼

Per CCAP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001633336), Crescent Capital BDC Inc. generated $276.3M in revenue (-7.6% YoY), $34.5M in net income, and $74.7M in free cash flow against $1.62B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.42 (+0.09%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 27% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY • 49.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-3.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CCAP)Realized 20D OHLCV Swing Band: ±5%

Deterministic 5-Pillar Attribution (51/100 Composite)

🔍 WHY CCAP SCORES 51/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+14/20 pts (27% of score)

SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$9.14-5.7% Next Q

Q2 (-2Q)

Grade D$8.62+3.2% Next Q

Q3 (-1Q)

Grade D$8.90+5.7% Next Q

Current

Grade D$9.41-1.3% Hist 90D α

Trajectory: D (43) → D (51)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CCAP Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CCAP currently carries a cautious 51/100 (D) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($9.54) and Max Pain ($9.88) forces dealer call-delta covering toward $15.94.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-1.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CCAP• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CCAP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 51%NO 49%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

53.330 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE15% OF RANGE

L: $8$9.41H: $15

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: D+RQD 11 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 19 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: D+RQD 21 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on CCAP

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (55)

-11.1% ROIC with 42.0% gross margin and 21.81% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 4.20 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (45)

19/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like CCAP

✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CCAP)

✓Walkthrough of CCAP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CCAP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -32.30%📐 HORIZONTAL RANGE

2026-11-03O $9.30H $9.41L $9.27C $9.41VOL 233.5K

RES: $12.25SUP: $8.08SMA50: $9.54SMA200: $11.65

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CCAP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CCAP Butterfly Map → + Track CCAP →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

-1.4%/yr Implied 5Y Growth

vs. -7.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CCAP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CCAP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CCAP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CCAP)

Financials Rank #626 of 1097 ⚔️ RM vs CCAP Full Matrix →

1. Head-to-Head Financials Peer Comparison (CCAP vs. RM, BRBI, GEMI, TREE)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, Crescent Capital BDC Inc. (CCAP) ranks #626 by composite RQD confidence (51/100, grade D) and #783 by equity capitalization ($341.6M). Within this direct 5-issuer industry benchmark cohort, RM leads on earnings valuation at 7.5x trailing P/E, while RM leads on capital efficiency and profitability with 11.9% ROIC and — gross margin. RM currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with CCAP at 51/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CCAP ACTIVE Crescent Capital BDC Inc.	D	51/100	9.9x	—	-11.1%	+1.56%	$341.6M	Benchmark Subject
RM Regional Management Corp.	C-	61/100	7.5x	—	11.9%	+8.02%	$334.9M	/rm-vs-ccap →
BRBI BRBI BR Partners S.A. ADSs	D	45/100	—	—	—	+3.55%	$353.5M	/brbi-vs-ccap →
GEMI Gemini Space Station Inc. (Class A)	E	24/100	—	—	-35.0%	-7.49%	$376.1M	/gemi-vs-ccap →
TREE LendingTree Inc.	D	50/100	—	—	8.6%	-3.08%	$392.3M	/tree-vs-ccap →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001633336 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Crescent Capital BDC Inc. (CCAP) reported GAAP revenue of $276.3M (-7.6% vs. FY2024 revenue of $299.0M , and -1.6% cumulative change since FY2023) , GAAP net income of $34.5M, operating cash flow of $74.7M, and free cash flow of $74.7M (+26.8% YoY). On the balance sheet, CCAP closed FY2025 with $1.62B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$276.3M	$34.5M	$74.7M	$74.7M	$1.62B	—
FY2024 (FY)	2024-12-31	$299.0M	$73.6M	$58.9M	$58.9M	$1.66B	—
FY2023 (FY)	2023-12-31	$280.8M	$83.8M	$92.3M	$92.3M	—	—

3. CCAP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CCAP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CCAP compare to RM and BRBI in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for CCAP?

Where is CCAP trading relative to its 50-day, 200-day, and 52-week technical levels?

CCAP last traded at $9.41 (+1.56% on volume of 103,027 shares), positioning the stock -1.36% below its 50-day simple moving average ($9.54) and -19.23% below its 200-day simple moving average ($11.65). Across its 52-week range of $8.40 to $15.18, CCAP sits at the 14.9% percentile with a 14-day RSI of 53.3 (NEUTRAL RANGE) and an implied next-earnings move of ±5.0% ($8.94 to $9.88).

Direct Sub-Reports: CCAP RQD Cockpit CCAP 12M Forecast CCAP Earnings & Move CCAP Dividends & DRIP CCAP Insiders & 13F CCAP Whale Options CCAP Profit Sankey CCAP News & Why

ROARABLE RATING BRIEF • RQD 51/100 (D) ✓ SEC XBRL & RQD VERIFIED

CCAP — Crescent Capital BDC Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Crescent Capital BDC Inc. (CCAP) earns a live Roarable RQD composite score of 51/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $9.41 (+1.56% 1D, market capitalization $341.6M).

Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of -11.1%, gross margin of —, operating margin of —, and free cash flow yield of 21.81%.
Whale 13F & Options Flow (5/20) + Insider Conviction (14/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Crescent Capital BDC Inc. (CCAP) is a NASDAQ-listed operating company in the Finance: Consumer Services industry (Financials sector) with an equity market capitalization of $341.6M. The business operates with a gross margin of 0%, an operating margin of 0%, and a return on invested capital (ROIC) of -11.1% (free cash flow yield of 21.81%). Within the Finance: Consumer Services peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Crescent Capital BDC Inc. (CCAP) reported $276.3M in annual revenue (up from $299.0M in FY2024, -7.6% YoY) and $34.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($280.8M revenue, $83.8M net income) through FY2025, CCAP scaled operating cash flow to $74.7M and free cash flow to $74.7M, backed by $1.62B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D • RQD 51/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 21.81% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $8.40 – $15.18 52-week range.
🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 9.9x trailing P/E against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Finance: Consumer Services (Financials), CCAP carries a macro regime beta of 1.00 and gross margin of —.

Key Question #1: Can CCAP sustain or expand its — operating margin and -11.1% ROIC against Finance: Consumer Services peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $276.3M and free cash flow of $74.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is CCAP's 9.2x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

CCAP Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Crescent Capital BDC Inc. (CCAP) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CCAP Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 22h ago

Crescent Capital BDC, Inc. Estimates – NASDAQ:CCAP

TradingView report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

Crescent Capital BDC, Inc. (CCAP) Seasonal Returns Chart

Yahoo! Finance Canada report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

Crescent Capital BDC (NASDAQ:CCAP) Stock Moved Up to "Hold" by Wall Street Zen

MarketBeat report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE 24/7 Wall St. • 1d ago

5 Overlooked Dividend Stocks Paying Up to 17.5%. Here’s the Catch

24/7 Wall St. report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GlobeNewswire • 1d ago

Crescent Capital BDC, Inc. Schedules Earnings Release and

GlobeNewswire report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Quiver Quantitative • 1d ago

Crescent Capital BDC Announces Third Quarter 2026 Earnings Release and Conference Call Date

Quiver Quantitative report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Stock Rated "Hold" by Sell-Side Analysts

MarketBeat report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Traders Daily • 1d ago

(CCAP) and the Role of Price-Sensitive Allocations

Stock Traders Daily report covering Crescent Capital BDC Inc. (CCAP) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CCAP Bull vs. Bear Conversation Board — What's Your Call at $9.41?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CCAP 🐻 33% BEARISH CONVICTION

MA MacroHawk_NYC RQD DEBATE OPENER • Cross-Asset Macro Desk 🐂 BULLISH 🎯 Target: $10.66 (+15.0%)

📌 Pinned Debate

A 21.81% FCF yield and a 9.9 trailing P/E suggest the cash generation may be undervalued relative to reported earnings.

A 21.81% FCF yield and a 9.9 trailing P/E suggest the cash generation may be undervalued relative to reported earnings.. When you look under the hood at CCAP, Fundamental Cash Engine is 11/20 with 0.0% gross margins and -11.1% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (5/20) has been quietly accumulating below $15.18. My 12M target is $10.66.

EarningsSniper 🐂 BULL

Both sides have a point here — CCAP's 13/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH 🎯 Target: $7.14 (-23.0%)

Spot @ $9.27

A -11.1% ROIC, zero reported revenue, and a D+ RQD score point to weak fundamentals and limited macro tailwind.

A -11.1% ROIC, zero reported revenue, and a D+ RQD score point to weak fundamentals and limited macro tailwind.. Look at the math on CCAP: paying 9.9x trailing P/E for -11.1% ROIC and 0.0% operating margins leaves zero margin of safety if Finance: Consumer Services demand softens. I'd wait for a retest of $8.16 before getting long.